J.P. Morgan upgrades Harte-Hanks (NYSE: HHS) from Neutral to Overweight. Price target increased ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE